Home > Products > CD30 & CD64 > Recombinant Human Anti-CD30 x Human Anti-CD64 Bispecific Antibody (scFv-IgG)

Recombinant Human Anti-CD30 x Human Anti-CD64 Bispecific Antibody (scFv-IgG)  (CAT#: BSSG-H286)

Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-CD30 antibody variable domain are respectively connected to the N terminus of the anti-CD64 IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget neutrophilscells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
Datasheet INQUIRY

Specifications

Targets
CD30 & CD64
Type
scFv-IgG
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL)
Host Animal 1
Human
Host Animal 2
Human

Targets

Target 1
CD30
Gene ID
UniProt ID
Alternative Names
TNFRSF8; tumor necrosis factor receptor superfamily, member 8; CD30; Ki-1; D1S166E; tumor necrosis factor receptor superfamily member 8; Ki-1 antigen; CD30L receptor; cytokine receptor CD30; lymphocyte activation antigen CD30
Target 2
CD64
Gene ID
UniProt ID
Alternative Names
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD30 & CD64"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD30 x Human Anti-CD64 Bispecific Antibody (scFv-IgG) (BSSG-H286). Click the button below to contact us or submit your feedback about this product.